Search

Author/Creator Diacon, Andreas H

2. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis. Issue 9979 (2nd May 2015)

Authors:
Dawson, Rodney; Diacon, Andreas H; Everitt, Daniel; van Niekerk, Christo; Donald, Peter R; Burger, Divan A; Schall, Robert; Spigelman, Melvin; Conradie, Almari; Eisenach, Kathleen; Venter, Amour; Ive, Prudence; Page-Shipp, Liesl; Variava, Ebrahim; Reither, Klaus; Ntinginya, Nyanda E; Pym, Alexand...
Journal:
Lancet
Issue:
Volume 385:Issue 9979(2015)
Page Start:
1738
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Face masks in the post-COVID-19 era: a silver lining for the damaged tuberculosis public health response?. Issue 4 (April 2021)

Authors:
Driessche, Koen Vanden; Mahlobo, Precious Z; Venter, Rouxjeane; Caldwell, Judy; Jennings, Karen; Diacon, Andreas H; Cotton, Mark F; de Groot, Ronald; Hens, Niel; Marx, Florian M; Warren, Robin M; Mishra, Hridesh; Theron, Grant
Journal:
Lancet
Issue:
Volume 9:Issue 4(2021)
Page Start:
340
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial Simulations. (28th April 2018)

Authors:
Svensson, Robin J; Svensson, Elin M; Aarnoutse, Rob E; Diacon, Andreas H; Dawson, Rodney; Gillespie, Stephen H; Moodley, Mischka; Boeree, Martin J; Simonsson, Ulrika S H
Journal:
Journal of infectious diseases
Issue:
Volume 218:Number 6(2018)
Page Start:
991
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial. Issue 1 (January 2017)

Authors:
Boeree, Martin J; Heinrich, Norbert; Aarnoutse, Rob; Diacon, Andreas H; Dawson, Rodney; Rehal, Sunita; Kibiki, Gibson S; Churchyard, Gavin; Sanne, Ian; Ntinginya, Nyanda E; Minja, Lilian T; Hunt, Robert D; Charalambous, Salome; Hanekom, Madeleine; Semvua, Hadija H; Mpagama, Stellah G; Manyama, Ch...
Journal:
Lancet infectious diseases
Issue:
Volume 17:Issue 1(2017:Jan.)
Page Start:
39
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial. Issue 7 (July 2021)

Authors:
Dooley, Kelly E; Rosenkranz, Susan L; Conradie, Francesca; Moran, Laura; Hafner, Richard; von Groote-Bidlingmaier, Florian; Lama, Javier R.; Shenje, Justin; De Los Rios, Jorge; Comins, Kyla; Morganroth, Joel; Diacon, Andreas H; Cramer, Yoninah S; Donahue, Kathleen; Maartens, Gary; Alli, Oladapo; ...
Journal:
Lancet infectious diseases
Issue:
Volume 21:Issue 7(2021)
Page Start:
975
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis. (21st March 2018)

Authors:
Svensson, Elin M; Svensson, Robin J; te Brake, Lindsey H M; Boeree, Martin J; Heinrich, Norbert; Konsten, Sarah; Churchyard, Gavin; Dawson, Rodney; Diacon, Andreas H; Kibiki, Gibson S; Minja, Lilian T; Ntingiya, Nyanda E; Sanne, Ian; Gillespie, Stephen H; Hoelscher, Michael; Phillips, Patrick P J...
Journal:
Clinical infectious diseases
Issue:
Volume 67:Number 1(2018)
Page Start:
34
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗